Remdesivir Could Be in Short Supply. Here’s a Fix.

The federal government must work to ensure adequate supply of the coronavirus drug — and distribute it evenly and transparently. New York Times By BY AMY KAPCZYNSKI, PAUL BIDDINGER AND ROCHELLE WALENSKY from NYT Opinion https://ift.tt/307N2GL
Remdesivir (Drug), Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Inventions and Patents, Generic Brands and Products